JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Beat H. Walpoth
Mustafa Cikirikcioglu
Ebrahim Khabiri
Afksendiyos Kalangos
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walpoth, B. H.
Right arrow Articles by Zisch, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walpoth, B. H.
Right arrow Articles by Zisch, A. H.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2007;133:1163-1170
© 2007 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology

Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model

Beat H. Walpoth, MDa,2, Prisca Zammaretti, PhDb,*, Mustafa Cikirikcioglu, MD, PhDa,*, Ebrahim Khabiri, MDa, M. Karim Djebaili, MDa, Jean-Claude Pache, MDc, Jean-Christophe Tille, MD, PhDc, Yacine Aggoun, MDd, Denis Morel, MDe, Afksendiyos Kalangos, MD, PhDa, Jeffrey A. Hubbell, PhDb,f, Andreas H. Zisch, PhDb,g,h,1

a Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
b Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
c Department of Clinical Pathology, University of Geneva, Switzerland
d Department of Anaesthesiology Research, University of Geneva, Switzerland
e Division of Pediatric Cardiology, University Hospital of Geneva, Switzerland
f Institute of Bioengineering, Swiss Federal Institute of Technology, Lausanne, Switzerland
g Department of Obstetrics, University Hospital of Zurich, Switzerland
h Center for Integrative Human Physiology of the University of Zurich, Switzerland.

Received for publication May 31, 2006; revisions received August 24, 2006; accepted for publication September 19, 2006.

1 Address for reprints: Andreas Zisch, PhD, Department of Obstetrics, University Hospital Zurich, Frauenklinikstr. 10, 8091 Zurich, Switzerland (Email: beat.walpoth{at}hcuge.ch; andreas.zisch{at}usz.ch).

2 Beat H. Walpoth, MD, Clinic of Cardiovascular Surgery, University Hospital Geneva, 1211 Geneva 14, Switzerland (Email: beat.walpoth{at}hcuge.ch; andreas.zisch{at}usz.ch).

Objective: Intimal hyperplasia and surface thrombogenicity are major factors in the high failure rate of synthetic small-diameter bypass grafts. Vascular endothelial growth factor is a potent stimulus for endothelial growth, and its provision in a fibrin matrix coating at the luminal graft surface may hold a key to spontaneous graft endothelialization and improved graft patency.

Methods: Pigs underwent bilateral carotid artery interposition of expanded polytetrafluoroethylene grafts either impregnated with fibrin (n = 11)—engineered to locally release vascular endothelial growth factor121 (vascular endothelial growth factor–fibrin; n = 11)—or left uncoated (n = 12). Graft patency was assessed by quantitative carotid angiography followed by graft histomorphometry at the 1-month experimental end point.

Results: Patency rates were not significantly different between study groups. Grafts coated with fibrin or vascular endothelial growth factor–fibrin exhibited significantly increased angiographic narrowing at the proximal anastomosis (for both P < .05 vs uncoated) and no difference at the distal anastomosis and the grafts’ middle. Histological analysis showed 80% to 90% endothelial coverage and buildup of intima throughout the lengths of all grafts. Examination of the grafts’ midportion revealed significantly enlarged neointimal layers of smooth muscle actin-positive cells in grafts coated with vascular endothelial growth factor–fibrin (242 ± 47 µm2/µ) and fibrin (177 ± 41 µm2/µ), compared with uncoated grafts (131 ± 39 µm2/µ) (for both P < .05 vs uncoated). This thickening could not be explained by enhanced inflammation or vessel wall angiogenesis, which were minimal at the experimental end point.

Conclusions: Fibrin and vascular endothelial growth factor produced effects deleterious to graft healing, by increasing the narrowing at proximal anastomosis and neointimal growth beyond that seen in uncoated grafts. It may reflect direct activation by exogenous vascular endothelial growth factor of vascular smooth muscle cells.

Abbreviations and Acronyms ePTFE = expanded polytetrafluoroethylene; SEM = scanning electron microscopy; TBS = tris-buffered saline; VEGF = vascular endothelial growth factor






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.